A Behavioral Application for Improving Smoking Cessation Among Smokers
Key facts
- Who runs it
- Fred Hutchinson Cancer Center
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 1,812 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 31 Jul 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Smartphone app-based Intervention (Actify! A app)
- Smartphone app-based Intervention (Actify! B app)
- Health Promotion and Education
- Survey Administration
- Record updated
- 12 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (23)Hide the full registry criteria
Who can take part
- Age 18 or older
- Currently smoke, averaging at least 5 cigarettes/day for the last 30 days
- Interested in quitting smoking in the next 30 days
- Experience downloading and using one or more apps on their smartphone
- Either screens negative for depression (Patient Health Questionnaire - 9 item [PHQ-9] score 0-4; n = 906) or screens positive for mild to moderately severe current depressive symptoms (PHQ-9 score 5-19; n = 906)
- Willing and able to complete all study activities and to receive compensation by mail
- Comfortable reading and writing in English
- Have a mobile data plan and/or access to WiFi to support the use of the assigned app
- Reside in the United States (US)
- Willing to provide information for an emergency contact in case of serious concerns about the participant's physical or mental health
Who cannot take part
- Self-report of currently receiving behavioral treatment for depression (e.g., psychotherapy or counseling, web- or app-based interventions); current use of pharmacotherapy for depression or for other mental health conditions that are not otherwise excluded is allowable (e.g., benzodiazepines, anticonvulsants, opioid agonists, antipsychotics)
- Currently receiving other smoking cessation treatments, including pharmacotherapies (nicotine replacement therapy, bupropion, or varenicline) and behavioral interventions (e.g. quitline counseling, other digital health programs), but excluding electronic (e)-cigarettes/vaping
- Previous use of the QuitGuide program
- Having a Google voice number as their primary phone number (due to association with fraudulent study entry attempts in our previous work)
- History of a suicide attempt
- Self-reported lifetime diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, antisocial personality disorder, or borderline personality disorder; or self-reported lifetime diagnosis of an alcohol or drug use disorder with use of the substance(s) in the past 30 days
- Severe depression (PHQ-9 ≥ 20)
- Current suicidal ideation reported on the PHQ-9
- Employees/family of investigator or study center
- Member of the same household as another participant
- Woman who is pregnant or breastfeeding, or planning to become pregnant
- Currently incarcerated
- Participated in earlier studies to develop the Actify! app
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Cigarette smoking-related carcinoma
Where in United States
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, United StatesContact: Jaimee Heffner, PhDNot yet recruiting
About the trial
What the trial wants to find out
This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.
The 2 groups in the trial
- Arm I (Actify! A app)Treatment being tested
Participants use the Actify! app, which helps users identify personal values and meaningful activities, prompts users to schedule and complete meaningful activities, visualizes progress towards meeting activity and smoking-related goals, and provides tailored messages, resources, daily tips, personalized feedback, inspirational messages, and user stories, for 8 weeks on study.
Treatment: Smartphone app-based Intervention (Actify! A app), Health Promotion and Education, and Survey Administration
- Arm II (Actify! B app)Existing treatment, for comparison
Participants use an app, which contains quit advice, tools for tracking smokefree days, progress and cravings, guidance on preparing to quit, managing cravings and withdrawal, recovering from slips, and a mood management feature, for 8 weeks on study.
Treatment: Smartphone app-based Intervention (Actify! B app), Health Promotion and Education, and Survey Administration
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Actify! An mHealth Mood Management Tool to Improve Population-Level Smoking Cessation
- Criteria questions
- Built from NCT07493252, who can take part
- Record updated
- 12 August 2026